|
There is a paucity of information on the path of mild to moderate persistent asthma in children. The study was taken up to understand the path of asthma in childhood and predictors of various categories of asthma (remitting, periodic, and persistent asthma).
The Childhood Asthma Management Program was a randomized, double-masked study and was carried in multiple centers. It evaluated 909 children with mild to moderate persistent asthma for a period of over 4 years wherein the patients were randomized to receive continuous therapy with either budesonide or nedocromil, each versus placebo. This treatment period was followed by a 4-year observational follow-up period.
Children were said to have remitting asthma (no asthma activity in the last year), persistent asthma (asthma activity in every 3 months) or periodic asthma (neither remitting nor persistent). A child was said to have asthma activity if there was contact with local medical provider, leave from school, visits to the emergency department (ED), and hospitalization as a result of asthma; wheezing or any other exercise-induced symptoms; or use of relievers or controllers.
55% of children had persistent asthma, 39% had periodic asthma and remaining had remitting asthma. The airway hyperresponsiveness, eosinophilia and asthma morbidity were found to improve over the study period in all the 3 categories of asthma.
Children with remitting asthma were at higher odds of lacking allergen sensitization as well as exposure to indoor allergens, milder asthma, older age, low airway hyper-responsiveness, higher pre-bronchodilator FEV 1 % predicted, lower FVC% percent predicted at baseline compared against those having persistent asthma (all p values being significant).
Childhood asthma remission is uncommon and unaffected by 4 years of anti-inflammatory controller therapy. Remission gets affected by presence of allergen sensitization and exposure, low lung function and airway greater hyper-responsiveness.
J Allergy Clin Immunol 2010;125: 359-66. |